Managing Myeloma
- 2010-09-22 - Early Results form Study Finds It Is Better To Dose Bortezomib After Melphalan Prior To Stem Cell Transplantation- The Myeloma Beacon
- 2010-09-21 - Minnesota cancer researchers net $26M for stem cell therapies-Med City News
- 2010-09-20 - Addition Of Bortezomib To Lenalidomide-Dexamethasone May Yield Better Prognosis For Myeloma Patients With Certain Chromosomal Abnormalities
- 2010-09-17 - Why AEterna Zentaris Is Worth Double-Seeking Alpha
- 2010-09-16 - Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma
- 2010-09-15 - Long-Term Study Shows Thalidomide Delays Disease Progression In Smoldering Multiple Myeloma But Causes Significant Side Effects- The Myeloma Beacon
- 2010-09-14 - Experts Recommend Against Donor Stem Cell Transplantation For Multiple Myeloma Patients Until Safety And Efficacy Is Improved-The Myeloma Beacon
- 2010-09-13 - CDC Event Announcement: A Live Training Program for the Multidisciplinary Myeloma Care Team September 25, 2010– New York, NY
- 2010-09-13 - Pat’s Place: Dealing With Dexamethasone Side Effects- Myeloma Beacon
- 2010-09-13 - September 11th First Responder Battles Cancer
- 2010-09-13 - Matlin's dad diagnosed with cancer
- 2010-09-09 - Tragara Pharmaceuticals Initiates Phase I Clinical Program for TG02-PR Newswire
- 2010-09-09 - Howard grants wish to dying woman
- 2010-09-08 - Onyx licenses to Ono Japanese rights to Carfilzomiband a related drug ONX0912.
- 2010-09-08 - Featured Clinical Trial- NCI Cancer Bulletin:Comparing Post-transplant Therapies for Multiple Myeloma Patients